Human milk has anti-oxidant properties to protect premature infants

Current Pediatric Reviews

Volumn 3, Issue 1, 2007, Pages 45-51

  Tsopmo, Apollinaire ^a   Friel, James K ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antioxidants; Human milk; Premature infants

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARNITINE; CAROTENOID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTEINE; ENZYME; GLUTATHIONE PEROXIDASE; GROWTH FACTOR; HORMONE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN; LACTOFERRIN; LACTOPEROXIDASE; MINERAL; OXYGEN; OXYGEN RADICAL; PEROXIDE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SPERMINE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOREDOXIN; UBIQUINONE; VITAMIN;

ANTIOXIDANT ACTIVITY; ARTERIAL OXYGEN TENSION; ARTIFICIAL MILK; BRAIN HEMORRHAGE; BREAST FEEDING; BREAST MILK; CHILD DEVELOPMENT; CHILD GROWTH; COPING BEHAVIOR; FOOD ANALYSIS; FOOD COMPOSITION; HUMAN; INFANT FEEDING; LUNG DYSPLASIA; NECROTIZING ENTEROCOLITIS; NUTRIENT SUPPLY; ORGANOGENESIS; OXYGEN CONSUMPTION; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; STORAGE TEMPERATURE;

EID: 33847248859     PISSN: 15733963     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339607779941615     Document Type: Review

References (87)

1. Barsky V, Siegel L. In: Friedman S, Sigman M Eds, The psychological development of low birth weight infants. Norwood NJ, Ablex. 1991; 275-98.
2. Saugstadt OD. Oxygen toxicity in the neonatal period. Acta Pediatr Scand 1990; 79: 881-92.
3. Sirven V, Beck G, Chrostowski D, Cardenas P, Boxer H, Frieri M. Monitoring circulating nitric oxide levels in infants with bronchopulmonary dysplasia for disease activity. Curr Ped Rev 2005; 1: 91-5.
4. Friel JK, Martin SM, Langdon M, Herzberg G, Buettner GR. Human milk provides better antioxidant protection than does infant formula. Pediatr Res 2002; 51: 612-8.
5. Shoji H, Shimizu T, Shinohara K, Oguchi S. Suppressive effects of breast milk on oxidative DNA damage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2004; 89: F136-8.
6. van Zoeren-Grobben D, Lindeman JH, Houdkamp E, Brand R, Schrijver J, Berger HM. Postnatal changes in plasma chain-breaking antioxidants in healthy preterm infants fed formula and/or human milk. Am J Clin Nutr 1994; 60: 900-6.
7. Goldman AS, Thorpe LW, Goldblum RM, Hanson KA. Anti-inflammatory properties of human milk. Acta Pediatr Scand 1986; 75: 689-95.
8. Buescher ES, McIllherhan SM. Antioxidant properties of human colostrum. Pediatr Res 1988; 24: 14-9.
9. Allen RG. Oxygen-reactive species and antioxidant responses during development: the metabolic paradox of cellular differentiation. Proc Soc Exp Biol Med 1991; 196: 117-29.
10. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18: 775-94.
11. Burdon RH. Control of cell proliferation by reactive oxygen species. Biochem Soc Trans 1996; 24: 1028-32.
12. Piazza RC, Poliquist DD, Gould LJ. Role of reactive oxygen species in regulating collagen metabolism in fibroblasts. J Surg Res 2004; 121: 320-0.
13. Hay WW, Bell E. Oxygen therapy, oxygen toxicity and the STOPROP trial. Pediatrics 2000; 105: 425-6.
14. Inder TE, Graham P, Sanderson K, Taylor BJ. Lipid peroxidation as a measure of oxygen free radical damage in the very low birth weight infant. Arch Dis Child Fetal Neonatal Ed 1994; 70: F107-11.
15. Acworth A. In: Bailey B Ed, The handbook of oxidative metabolism. United Kingdom, ESA, Inc, 2002.
16. Bulkley GB. Free radicals and other reactive oxygen metabolites: clinical relevance and the therapeutic efficacy of antioxidant therapy. Surgery 1993; 113: 479-83.
17. Walther FJ, David-Cu R, Lopez SL. Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Amer J Phys 1995; 269: L613-7.
18. McCord JM. Superoxide production and human disease. In: Jesaitis A, Dratz E, Eds, Molecular basis of oxidative damage by leukocytes. Boca Raton FI, CRC Press 1992; 225-39.
19. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vanter SF. Regional myocardial function and electrophysiological alterations after brief coronary occlusion in conscious dogs. J Clin Invest 1975; 56: 978-85.
20. Sharma MK, Buettner GF, Spencer KT, Kerber RE. Ascorbyl free radical as a real-time marker of free radical generation in briefly ischemic and refused hearts: an electron paramagnetic resonance study. Clin Res 1994; 74: 650-8.
21. Nelson SK, Bose SK, McCord JM. The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic Biol Med 1994; 16: 195-200.
22. Saugstadt OD. Oxygen radical disease in neonatology. Semin Neonatol 1998; 3: 239-44.
23. Sullivan JL, Newton RB. Serum antioxidant activity in neonates. Arch Dis Child 1988; 63: 748-50.
24. Wispe JR, Bell EF, Roberts RJ. Assessment of lipid peroxidation in newborn infant and rabbits by measurements of expired ethane and pentane: influence of parenteral lipid infusion. Pediatr Res 1985; 19: 374-9.
25. Volpe JJ. Brain injury in the premature infant: is it preventable? Pediatr Res 1990; 27(Suppl 6): S28-33.
26. Noseworthy MD, Bray TM. Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measured by dynamic MRI. Proc Soc Exp Biol Med 2000; 223: 175-82.
27. Ambalavanan N, Carlo WA. Bronchopulmonary dysplasia: new insights. Clin Perinatol 2004; 31: 613-28.
28. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
29. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial. 1. Primary outcomes. Pediatrics 2000; 105: 295-310.
30. Kelly FJ. Free radical disorders of preterm infants. Brit Med Bull 1993; 49: 668-78.
31. Berger TM, Polidori MC, Dabbagh A, et al. Antioxidant activity of vitamin C in iron overloaded human plasma. J Biol Chem 1997; 272: 15656-60.
32. Berger HM, Mumby S, Gutteridge JMC. Ferrous ions detected in iron-overloaded cord blood plasma from preterm, and term babies: implications for oxidative stress. Free Radic Biol Med 1995; 22: 555-9.
33. Halliwell B. In: Ziegler EE, Filer LJ Eds, Present Knowledge in Nutrition. Washington DC, ILSI Press 1996; 234-245.
34. Pitkanen OM, Hallman M, Andersson SM. Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birthweight infants. J Pediatr 1990; 116: 760-4.
35. Gladstone IM, Levine RL. Oxidation of proteins in neonatal lungs. Pediatrics 1994; 93: 764-8.
36. Gutcher GR, Raynor WJ, Farrell PM. An evaluation of vitamin E status in premature infants. Am J Clin Nutr 1984; 40: 1078-89.
37. Silvers KM, Gibson AT, Powers HE. High plasma vitamin C concentration at birth associated with low antioxidant status and poor outcome in premature infants. Arch Dis Child Fetal Neonatal Ed 1994; 71: F40-4.
38. Schmidt H, Gruie T, Rainer M, Siems WG, Wauer RR. Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia. Pediatr Res 1996; 40: 15-20.
39. Lubec G, Widness JA, Hayde M, Menzel D, Pollak A. Hydroxyl radical generation in oxygen-treated infants. Pediatrics 1997; 100: 700-4.
40. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm babies. Pediatr Res 2000; 47: 221-4.
41. Ogihara T, Hirano K, Morinobu T, et al. Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999; 80: F21-5.
42. Phylactos AC, Leaf AA, Costeloe K, Crawford MA. Erythrocyte copper/zinc superoxide dismutase exhibits reduced activity in preterm and low birth weight infants at birth. Acta Paediatr 1985; 84: 1421-5.
43. Grigg J, Barber A, Silverman M. Bronchoalveolar lavage fluid glutathione in intubated premature infants. Arch Dis Child 1993; 69: 49-51.
44. Collard KJ, Godeck S, Holley JE, Quinn MW. Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. Arch Dis Child Fetal Neonatal Ed 2004; 89: F412-6.
45. Jain A, Mehta T, Auld PA, et al. Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures. Pediatr Pulmol 1995; 3: 160-6.
46. Smith CV, Hansen TN, Martin NE, McMicken HW, Elliott SJ. Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res 1993; 34: 360-5.
47. Wang TG, Gotoh Y, Jennings MH, Rhoads CA, Aw TY. Lipid hydroperoxide-induced apoptosis in human colonic CaCo-2 cells is associated with an early loss of cellular redox balance. FASEB J 2000; 14: 1567-76.
48. Rao R, Baker RD, Baker SS. Inhibition of oxidant-induced barrier disruption and protein tyrosine phosphorylation in Caco-2 cell monolayers by epidermal growth factor. Biochem Pharmacol 1999; 57: 685-95.
49. Catassi C, Bonucci A, Coppa GV, Carlucci A, Giorgi PL. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Pediatr Gastroenterol Nutr 1995; 21: 383-6.
50. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 2000; 97: 6043-8.
51. Halliwell B. Antioxidants in human health and disease. Ann Rev Nutr 1996; 16: 33-50.
52. Sosenko IR, Innis S, Frank L. Intralipid increases long polyunsaturated fatty acids and protects newborn rats from oxygen toxicity. Pediatr Res 1991; 30: 413-7.
53. Moison RMW, Palinckx JJS, Poest M, Houdkamp E, Berger HM. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993; 341: 79-82.
54. Frank L. Antioxidants, nutrition, and bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 541-62.
55. Autor AP, Frank L, Roberts RJ. Developmental characteristics of pulmonary SOD: relationship to RDS. Pediatr Res 1976; 10: 154-8.
56. Sosenko IR, Chen Y, Price LT, Frank L. Failure of premature rabbits to increase lung antioxidant enzyme activities after hyperoxic exposure: antioxidant enzyme gene expression and pharmacologic intervention with endotoxin and dexamethasone. Pediatr Res 1995; 37: 469-75.
57. Belizi S, Nazarova IA, Klimova IA, Prokofev VN, Pushkina NV. Antioxidant properties of lactoferrin from human milk. B Exp Biol Med 1999; 127: 471-3.
58. Raghuveer TS, Mcguire EM, Martin SM, et al. Lactoferrin in the preterm, infants' diet attenuates iron-induced oxidation products. Pediatr Res 2002; 52: 964-72.
59. Cunningham AS. Breast feeding, antioxidants and the retinopathy of prematurity. Am J Obstet Gynecol 1987; 156: 1040-1.
60. Anderson GH. Human milk feeding. Pediatr Clin North Am 1985; 32: 335-353.
61. Diehl-Jones WL, Askin DF. Nutritional modulation of neonatal outcomes. AACN Clin Issues 2004; 15: 83-96.
62. Host A, Bahna SL. In: Frieri M, Kettelhut Eds, Food Hyper-sensitivity and Adverse Reactions A Practical Guide for Diagnosis and Management. New York, Marcel Dekker 1999; 99-111.
63. Theratill JM, Bahna SL. In: Frieri M, Kettelhut Eds, Food Hypersensitivity and Adverse Reactions A Practical Guide for Diagnosis and Management. New York, Marcel Dekker 1999; 477-83.
64. Turoli D, Testolin G, Zanini R, Bellù R. Determination of oxidative status in breast and formula milk. Acta Paediatr 2004; 93: 1569-74.
65. L'Abbe M, Friel JK. Glutathione peroxidase and superoxide dismutase concentrations in milk from mothers of premature and full-term infants. J Pediatr Gastr Nutr 2000; 31: 270-4.
66. Lindmark-Månsson H, Åkesson B. Antioxidative factors in milk. Br J Nutr 2000; 84(Suppl. 1): S103-10.
67. Asada K. Occurrence of superoxide dismutase in bovine milk. Agric Biol Chem 1976; 40: 1659-60.
68. Hirvi Y, Griffiths MW. Milk catalase activity as an indicator of thermization treatments used in the manufacture of cheddar cheese. J Dairy Sci 1998; 81: 338-45.
69. Hojo Y. Selenium concentration and glutathione peroxidase activity in cows milk. Biol Trace Elem Res 1982; 4: 233-9.
70. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 1992; 119: 598-620.
71. Arrigoni O, De Tullio MC. Ascorbic acid: much more than just an antioxidant. Biochim Biophys Acta 2002; 1569: 1-9.
72. Picciano MF. Human milk: nutritional aspects of a dynamic food. Biol Neonate 1988; 74: 84-93.
73. Lucas A, Cole TJ. Breast milk and necrotizing enterocolitis. Lancet 1990; 336: 1519-23.
74. Issaacs CE, Pascal T, Wright CE, Gaull GE. Sulfhydryl oxidase in human milk: stability of milk enzymes in the gastrointestinal tract. Pediatr Res 1984; 18: 532-5.
75. Shoji H, Oguchi S, Shimizu T, Yamashiro Y. Effect of human breast milk on urinary 8-hydroxy-2′-deoxyguanosine excretion in infants. Pediatr Res 2003; 53: 850-2.
76. Abbott Laboratories. Composition of feedings for infants and young children. Washington DC, Ross Products Division, Columbus OH, 1999; 1-17.
77. Hanna N, Ahmed K, Anwar M, Petrova A, Hiatt M, Hegyi T. Effect of storage on breast milk antioxidant activity. Arch Dis Child Fetal Neonatal Ed 2004; 89: F518-20.
78. Miranda M, Muriach M, Almansa I, et al. Oxidative status of human milk and its variations during cold storage. BioFactors 2004; 20: 129-37.
79. Hamosh M. Bioactive components of human milk: more than just nutrition. Pediatric Basics 2002; 99: 2-11.
80. Coppa GV, Pierani P, Zampini L, Bruni S, Carloni I, Gabrielli O. In: Newburg DS Ed, Bioactive components of human milk. New York, Kluwer Academic 2001; 307-14.
81. Shoji H, Oguchi S, Fujinaga S, et al. Effects of human milk and spermine on hydrogen peroxide-induced oxidative damage in IEC-6 cells. J Ped Gastroent Nutr 2005; 41: 460-5.
82. Canfield LM, Clandinin MT, Davies DP, et al. Multinational study of major breast milk carotenoids of healthy mothers. Eur J Nutr 2003; 42: 133-41.
83. Todoroki Y, Tsukahara H, Ohshima Y, et al. Concentrations of thioredoxin, a redox-regulating protein, in umbilical cord blood and breast milk. Free Rad Biol Med 2005; 39: 291-297.
84. Quiles JL, Ochoa JJ, Ramirez-Tortosa MC, et al. Coenzyme Q concentration and total antioxidant capacity of human milk at different stages of lactation in mothers of preterm and full-term infants. Free Radic Res 2005; 40: 199-206.
85. Gothefors L, Marklund S. Lactoperoxidase activity in human milk and in saliva of newborn infants. Infect Immun 1975; 11: 1210-15.
86. Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci 2006; 78: 803-11.
87. Kelder B, Erney R, Kopchick J, Cummings R, Prieto P. In: Newburg DS Ed, Bioactive components of human milk New York, Kluwer Academic 2001; 269-78.